14Apr
M&A Litigation Rising Amidst COVID-19 Uncertainty: Considerations for Litigators and Deal-Makers
Just as no human being is naturally immune to the COVID-19 virus, no industry is immune to its economic effects—and related M&A activity across all industries proves no exception. In the weeks following the issuance of stay-at-home orders in states...
By:
White and Williams LLP
Related
A private equity (PE) transaction can give a physicians group more room to focus on clinical care as...
Read More >
On April 8, 2020, New Jersey Governor Phil Murphy signed Executive Order No. 122, requiring the clos...
Read More >
On July 9 and October 12, 2020, the Delaware Supreme Court added two more opinions to its growing su...
Read More >
In yesterday’s State of the State, Governor Andrew Cuomo proposed legislation that would require pr...
Read More >
On October 29, 2019, the Seventh Circuit held that Burlington Northern Santa Fe Railway Company (“B...
Read More >
On August 26, 2019, we wrote of the plan by the U.S. Department of Labor’s Wage and Hour Division (...
Read More >